Chanca piedra has 4 commonly claimed benefits, and 1 of them rests on 2 human studies while the other 3 rest on tradition. That ratio is the story.
This article grades each claim by what was measured, including the trial result that is quoted everywhere with its p value removed.
Quick Answer: What Are the Real Benefits?
Kidney stone support is the only claim with controlled human data, and it is modest: a pooled analysis of 2 studies found standardised mean differences of -0.39 for stone size and -0.38 for number. Urinary calcium effects have been studied separately. Liver and gallstone claims rest on tradition and on research into other Phyllanthus species.
Key Takeaways
- Only 1 of the 4 claims has controlled human trial data behind it.
- The pooled analysis found stone size down by 0.39 standardised units.
- That analysis included only 2 qualifying human studies in total.
- Urinary calcium normalisation has been examined in 1 group of stone formers.
- Hepatitis research covers Phyllanthus species broadly, not only this 1 herb.
Related Products
How to Read a Chanca Piedra Claim
This herb has an unusually clean evidence hierarchy, which makes grading straightforward. There are 2 controlled studies on stones, 1 study on urinary chemistry, and then tradition.
- Tier 1: Kidney stone burden, 2 controlled studies pooled.
- Tier 2: Urinary calcium in stone formers, examined separately.
- Tier 3: Hepatitis B, in Phyllanthus species research generally.
- Tier 4: Gallstones, weight loss and detox, with 0 human trials.
The background on the plant and its name is in our chanca piedra overview.
Benefit 1: Stone Burden After Lithotripsy
This is the supported claim, and its size is modest. A meta-analysis pooling the available controlled human data on stone size and number found significant but small effects, from a total of 2 qualifying studies.[1]Phyllanthus niruri (stone breaker) herbal therapy for kidney stones; a systematic review and meta-analysis of clinical efficacy, and Google Trends analysis of public interest — Canadian Journal of Urology View source
| Outcome | Pooled result | Reading |
|---|---|---|
| Mean stone size | SMD -0.39 cm, p = 0.01 | Statistically significant, small |
| Mean stone number | SMD -0.38, p = 0.01 | Statistically significant, small |
| Studies included | 2 | The whole evidence base |
| Authors' wording | Modest efficacy, pending further study | Their conclusion, not ours |
Two studies is not a body of evidence, and the authors said so. It is also 2 more controlled studies than most herbs in this category can claim.
Benefit 2: The Lithotripsy Trial in Detail
The larger of those 2 studies is the one quoted on nearly every product page, usually without its p value. It followed 150 patients after shock wave lithotripsy, with 78 taking 2 g of extract daily for at least 3 months.[2]Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, long-term study — The Journal of Urology View source
- Overall: 93.5% versus 83.3% stone-free, p = 0.48.
- Lower calyx subgroup: 93.7% versus 70.8%, p = 0.01.
- Subgroup size: 56 of the 150 patients.
- Safety: No side effects recorded in either group.
A subgroup finding in 56 people is a reason for further study rather than a marketing headline. The full reading is in chanca piedra for kidney stones.
Benefit 3: Urinary Calcium
A separate line of work examined what the herb does to urinary chemistry rather than to stones themselves, in patients who form calcium stones.[3]Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients — Urological Research View source
- What was studied: Elevated urinary calcium in stone formers.
- Why it matters: High urinary calcium is 1 driver of stone formation.
- What it is not: Proof that fewer stones form over years.
- Status: Mechanistic support rather than an outcome trial.
Benefit 4: Liver and Hepatitis Claims
Chanca piedra appears in liver marketing because of research into the wider Phyllanthus genus in chronic hepatitis B. That research exists, and it does not say what the marketing implies.
| What people claim | What the research is |
|---|---|
| Chanca piedra treats hepatitis B | Cochrane reviews of Phyllanthus SPECIES, with cautious conclusions |
| It detoxifies the liver | No human trial measures anything called detoxification |
| It dissolves gallstones | 0 human trials located |
| It protects the liver generally | Preclinical work, not outcome evidence |
The honest version of those 2 topics is set out in gallstones and liver health.
Where It Sits Against Hydration
Any honest benefits page for a stone supplement has to name the comparison. Pooled across 9 studies, including 2 randomised trials with 269 patients and 7 observational studies with 273,685 people, high fluid intake was associated with a relative risk of 0.40 for stone events.[4]Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis — Journal of Nephrology View source
- Hydration: 9 studies, hundreds of thousands of people.
- Chanca piedra: 2 studies in the pooled analysis.
- Order of priority: Fluids first, herb second at most.
- Cost: Water is free; the herb is not.
Anyone still interested after that comparison can run a defined trial with 2 capsules of 1000 mg daily, which is the amount the trial actually used.
Frequently Asked Questions
What is chanca piedra good for? +
Kidney stone support is the only claim with controlled human data, and it is modest: pooled standardised mean differences of -0.39 for stone size and -0.38 for number, from 2 studies. Other claims rest on tradition.
How strong is the evidence for chanca piedra? +
Weaker than the marketing suggests and stronger than nothing. The meta-analysis included 2 studies, and the largest trial's headline result of 93.5% versus 83.3% was not statistically significant at p = 0.48.
Does chanca piedra reduce stone size? +
In pooled data, yes, by a standardised mean difference of -0.39 with p = 0.01. That is a small effect drawn from 2 studies, and the authors described it as modest efficacy pending further study.
Does chanca piedra lower urinary calcium? +
One study examined exactly that in calcium stone formers with elevated urinary calcium. It is mechanistic support rather than proof that fewer stones form over the following 5 years.
Does chanca piedra have proven liver benefits? +
Liver marketing borrows from 2 Cochrane reviews of Phyllanthus species in chronic hepatitis B, which reached cautious conclusions. There is no human trial showing that this herb detoxifies a healthy liver.
Is chanca piedra proven for gallstones in humans? +
There are 0 human trials for gallstones. They form differently from kidney stones and sit in a different organ, so kidney stone data do not transfer. Gallstone symptoms need medical assessment.
Does chanca piedra help with weight loss? +
No controlled human trial supports that use. It sits in the same unsupported tier as detox claims, which is tier 4 of the 4 evidence levels used on this page.
Is chanca piedra better than drinking more water? +
No. Pooled across 9 studies covering more than 273,000 people, high fluid intake gave a relative risk of 0.40 for stone events. The herb has 2 studies. Fluids come first by a wide margin.
Does chanca piedra work for everyone with stones? +
The clearest benefit appeared in a subgroup of 56 patients with lower caliceal stones, at 93.7% versus 70.8%. Overall, across all 150 patients, the difference was not significant, so location may matter.
How long do I need to take it to see a benefit? +
The trial gave it for at least 3 months and measured clearance over 180 days. Any personal trial should be planned around that timeframe rather than around 2 or 3 weeks.
Should I take chanca piedra if I have never had a stone? +
There is no prevention trial in people who have never formed stones. If prevention is the goal, the evidence points firmly at fluid intake and diet rather than at a herb with 2 supporting studies.
Related Reading
Related Products
